Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients

NeuroImage

Volumn 17, Issue 3, 2002, Pages 1638-1648

  Chang, Linda ^a,b   Ernst, Thomas ^a,b   Witt, Mallory D ^b   Ames, Nina ^b   Gaiefsky, Megan ^a   Miller, Eric ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; HIV; Magnetic resonance spectroscopy; MRS; Neuropsychological tests

Indexed keywords

CD4 ANTIGEN; CHOLINE; CREATININE; INOSITOL; LIPID; TRITIUM;

ACCURACY; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; ASSOCIATION; BASAL GANGLION; BRAIN LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GLIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; LIPID BLOOD LEVEL; MALE; METABOLITE; MOTOR ACTIVITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; TASK PERFORMANCE; VIRUS LOAD; WHITE MATTER;

EID: 0036432622     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.2002.1254     Document Type: Article

References (54)

1. Anonymous Army Individual Test Battery: Manual of Directions and Scoring. 1944. War Department, Adjutant General's Office, Washington, DC.
2. Aronow, H. A., Brew, B. J., and Price, R. W. 1988. The management of the neurological complications of HIV infection and AIDS. AIDS 2: 151-159.
3. Barker, P. B., Lee, R. R., and Mcarthur, J. C. 1995. AIDS dementia complex: Evaluation with proton MR spectroscopic imaging. Radiology 195: 58-64.
4. Blair, J., and Spreen, O. 1989. The New Adult Reading Test-Revised Manual, University of Victoria, Victoria, Canada.
5. Bottomley, P. A. 1987. Spatial localization in NMR spectroscopy in vivo. Ann. NY Acad. Sci. 508: 333-348.
6. Chang, L., Ernst, T., Leonido-Yee, M., and Speck, O. 2000a. Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology 54: 389-396.
7. Chang, L., Ernst, T., Leonido-Yee, M., Walot, I., and Singer, E. 1999a. Cerebral metabolite abnormalities correlate with clinical severity of HIV-cognitive motor complex. Neurology 52: 100-108.
8. Chang, L., Ernst, T., Leonido-Yee, M., Witt, M., Speck, O., Walot, I., and Miller, E. N. 1999b. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53: 782-789.
9. Chang, L., Ernst, T., Witt, M., Jocivich, J., Walot, I., Desilva, M., Ames, N., Trivedi, N., and Miller, E. 2000b. Cerebral metabolite abnormalities in antiretroviral-näive HIV patients before and after HAART. Neurology 54: S47.002.
10. Chang, L., Speck, O., Miller, E., Braun, A., Jovicich, J., Koch, C., Itti, L., and Ernst, T. 2001. Neural correlates of attention and working memory deficits in HIV patients. Neurology 57: 1001-1007.
11. Chong, W. K., Sweeney, B., Wilkinson, I. D., Paley, M., Hall-Craggs, M. A., Kendall, B. E., Shepard, J. K., Beecham, M., Miller, R. F., Weller, I. V., Newman, S. P., and Harrison, M. J. 1993. Proton spectroscopy of the brain in HIV infection: Correlation with clinical, immunologic and MR imaging findings. Radiology 188: 119-124.
12. Cohen, J. 1998. Failure isn't what it used to be . . . but neither success. Science 279: 1133-1134.
13. Dautry, C., Vaufrey, F., Brouillet, E., Bizat, N., Henry, P., Conde, F., Bloch, G., and Hantraye, P. 2000. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J. Cereb. Blood Flow Metab. 20: 789-799.
14. 1H MR spectroscopy of the frontal lobe. Magn. Reson. Med. 36: 462-468.
15. Ernst, T., Kreis, R., and Ross, B. D. 1993. Absolute quantitation of water and metabolites in the human brain. I: Compartments and water. J. Magn. Reson. B 102: 1-8.
16. Gray, F., Scaravilli, F., Everall, I., Chretien, F., An, S., Boche, D., Adle-Biassette, H., Wingertsmann, L., Durigon, M., Hurtrel, B., Chiodi, F., Bell, J., and Lantos, P. 1996. Neuropathology of early HIV-1 infection. Brain Pathol. 6: 1-15.
17. Jarvik, J. G., Lenkinski, R. E., Grossman, R. I., Gomori, J. M., Schnall, M. D., and Frank, I. 1993. Proton MR spectroscopy of HIV-infected patients: Characterization of abnormalities with imaging and clinical correlation. Radiology 186: 739-744.
18. Jarvik, J. G., Lenkinski, R. E., Saykin, A. J., Jaans, A., and Frank, I. 1996. Proton spectroscopy in asymptomatic HIV-infected adults: Initial results in a prospective cohort study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13: 247-253.
19. Kløve, H. 1963. Clinical neuropsychology. In The Medical Clinics of North America (F. Forster, Ed.), Vol. 46, pp. 110-125. WB Saunders, New York.
20. Kreis, R., Ernst, T., and Ross, B. D. 1993. Absolute quantitation of water and metabolites in the human brain. II: Metabolite concentrations. J. Magn. Reson. B 102: 9-19.
21. Laubenberger, J., Haussinger, D., Bayer, S., Thielemann, S., Schneider, B., Mundinger, A., Hennig, J., and Langer, M. 1996. HIV-related metabolic abnormalities in the brain: Depiction with proton MR spectroscopy with short echo times. Radiology 199: 805-810.
22. Lewis, W., and Dalakas, M. 1995. Mitochondrial toxicity of antiviral drugs. Nature Med. 1: 417-422.
23. Marcus, C., Taylor-Robinson, S., Sargentoni, J., Ainsworth, J., Frize, G., Easterbrook, P., Shaunak, S., and Bryant, D. 1998. 1H MR spectroscopy of the brain in HIV-1 seropositive subjects evidence for diffuse metabolic abnormalities. Metab. Brain Dis. 13: 123-136.
24. Masdeu, J. C., Yudd, A., Van Heertun, R. L., Grundman, M., Hriso, E., O'connell, R. A., Luck, D., Camli, U., and King, L. N. 1991. Single photon emission computed tomography in human immuno-deficiency virus encephalopathy: A preliminary report. J. Nucl. Med. 32: 1471-1475.
25. Mcarthur, J. C., Cohen, B. A., Selnes, O. A., Kumar, A. J., Cooper, K., Mcarthur, J. H., Soucy, G., Cornblath, D. R., Chmiel, J. S., Wang, M., Starkey, D. L., Ginzburg, H., Ostrow, D. G., Johnson, R. T., Phair, J. P., and Polk, B. F. 1989. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: Results from the Multicenter AIDS Cohort Study. Ann. Neurol. 26: 601-611.
26. Mcarthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., Graham, N. M. H., Mcarthur, J. H., Selnes, O. A., Jacobson, L. P., Visscher, B. R., Concha, M., and Saah, A. 1993. Dementia in AIDS patients: Incidence and risk factors. Neurology 43: 2245-2252.
27. Meyerhoff, D., Bloomer, C., Cardenas, V., Norman, D., Weiner, M., and Fein, G. 1999. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 52: 995-1003.
28. Meyerhoff, D., Weiner, M., and Fein, G. 1996. Deep gray matter structures in HIV infection: A proton MR spectroscopic study. Am. J. Neuroradiol. 17: 973-978.
29. Miller, E. N. 1990. California Computerized Assessment Package (Custom Edition). Norland Software, Los Angeles.
30. Miller, E. N., Selnes, O. A., Mcarthur, J. C., Satz, P., Becker, J. T., Cohen, B. A., Sheridan, K., Machado, A. M., Van Gorp, W. G., and Visscher, B. 1990. Neuropsychological performances in HIV-1 infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology 40: 197-203.
31. Moller, H., Vermathen, P., Lentschig, M., Schuierer, G., Schwarz, S., Wiedermann, D., Evers, S., and Husstedt, I. 1999. Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J. Magn. Reson. Imaging 9: 10-18.
32. Navia, B. A., Jordan, B. D., and Price, R. W. 1986. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19: 517-524.
33. Paley, M., Cozzone, P., Alonso, J., Vion-Dury, J., Confort-Gouny, S., Wilkinson, I., Chong, W., Hall-Craggs, M., Harrison, M., Gili, J., Rovira, A., Capellades, J., Rio, J., Ocana, I., Nicoli, F., Dhiver, C., Gastaut, J., Gastaut, J., Wicklow, K., and Sauter, R. 1996. A multicenter proton magnetic spectroscopy study of neurological complications of AIDS. AIDS Res. Hum. Retroviruses 12: 213-222.
34. Paley, M., Wilkinson, I. D., Hall-Craggs, M. A., Chong, W. K., Chinn, R. J., and Harrison, M. J. 1995. Short echo time proton spectroscopy of the brain in HIV infection/AIDS. Magn. Reson. Imaging 13: 871-875.
35. Power, C., Kong, P. A., Crawford, T. O., Wesselingh, S., Glass, J. D., Mcarthur, J. C., and Trapp, B. D. 1993. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann. Neurol. 34: 339-350.
36. Radloff, L. L. 1977. The CES-D scale: A self-report depression scale for research in the general population. Appl. Psychol. Meas. 1: 385-401.
37. Rey, A. 1941. L'examen psycholoqiue dans les cas d'encephalopathie traumatique. Arch. Psychol. 28: 286-340.
38. Rottenberg, D. A., Moeller, J. R., Strother, S. C., Sidtris, J. J., Navia, B. A., Dhawan, V., Ginos, J. Z., and Price, R. W. 1987. The metabolic pathology of the AIDS dementia complex. Ann. Neurol. 22: 700-706.
39. Rottenberg, D. A., Sidtis, J. J., Strother, S. C., Schaper, K. A., Anderson, J. R., Nelson, M. J., and Price, R. W. 1996. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J. Nucl. Med. 37: 1133-1141.
40. Sacktor, N. C., Skolasky, R. L., Lyles, R. H., Mcfarlane, G., Anderson, D. E., Miller, E. N., Selnes, O. A., Becker, J., Wesch, J., and Mcarthur, J. C. 1998. Highly active antiretroviral therapy (HAART) improves cognitive impairment in HIV+ homosexual men. J. Neurovirol. 4: 365.
41. Salvan, A., Vion-Dury, J., Confort-Gouny, S., Nicoli, F., Lamoureux, S., and Cozzone, P. 1997. Brain Proton magnetic resonance spectroscopy in HIV-related encephalopathy: Identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res. Hum. Retroviruses 13: 1055-1066.
42. Simone, I., Federico, F., Tortorella, C., Andreula, C., Zimatore, G., Giannini, P., Angarano, G., Lucivero, V., Picciola, P., Cazrrara, D., Bellacosa, A., and Livrea, P. 1998. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J. Neurol. Neurosurg. Psychiatry 64: 516-523.
43. Smith, A. 1982. Symbol Digit Modalities Test. Western Psychological Services.
44. Stankoff, B., Tourbah, A., Suarez, S., Turell, E., Stievenart, J., Payan, C., Coutellier, A., Herson, S., Baril, L., Bricaire, F., Calvez, V., Cabanis, E., Lacomblez, L., and Lubetzki, C. 2001. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology 56: 112-115.
45. Stroop, J. 1935. Studies of interference in serial verbal reaction. J. Exp. Psychol. 18: 643-662.
46. Suwanwelaa, N., Phanuphak, P., Phanthumchinda, K., Suwanwela, N., Tantivatana, J., Ruxrungtham, K., Suttipan, J., Wangsuphachart, S., and Hanvanich, M. 2000. Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn. Reson. Imaging 18: 859-865.
47. Tatsch, K., Schielke, E., Bauer, W. M., Markl, A., Einhaupl, K. M., and Kirsch, C. M. 1990. Functional and morphological findings in early and advanced stages of HIV infection. A comparison of 99mTc-HMPAO SPECT with CT or MRI studies. Nuklearmedizin 29: 252-258.
48. Tracey, I., Carr, C. A., Guimaraes, A. R., Worth, J. L., Navia, B. A., and Gonzalez, R. G. 1996. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study. Neurology 46: 783-788.
49. Tracey, I., Hamberg, L. M., Guimaraes, A. R., Hunter, G., Chang, I., Navia, B. A., and Gonzales, R. G. 1998. Increased cerebral blood volume in HIV-positive patients detected by functional MRI. Neurology 50: 1821-1826.
50. Von Giesen, H., Antke, C., Hefter, H., Wenserski, F., Seitz, R., and Arendt, G. 2000. Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: Electrophysiologic and positron emission tomography findings. Arch. Neurol. 57: 1601-1607.
51. Von Giesen, H., Wittsack, H., Wenserski, F., Koller, H., and Arendt, G. 2001. Basal ganglia metabolite abnormalities in minor motor disorder associated with human immunodeficiency virus type 1. Arch. Neurol. 58: 1281-1286.
52. Wiley, C. A., Masliah, E., and Morey, M. 1991. Neocortical damage during HIV infection. Ann. Neurol. 29: 651-657.
53. Wilkinson, I., Miller, R., Miszkiel, K., Paley, M., Hall-Craggs, M., Baldeweg, T., Williams, I., Carter, S., Newman, S., Kendall, B., Catalan, J., Chinn, R., and Harrison, M. 1997a. Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection. AIDS 11: 289-295.
54. Wilkinson, I. D., Lunn, S., Miszkiel, K. A., Miller, R. F., Paley, M. N., Williams, I., Chinn, R. J., Hall-Craggs, M. A., Newman, S. P., Kendall, B. E., and Harrison, M. 1997b. Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS. JNNP 63: 477-482.